The heart and estrogen/progestin replacement study revisited: Hormone replacement therapy produced net harm, consistent with the observational data

Archives of Internal Medicine

Volumn 160, Issue 19, 2000, Pages 2897-2900

  Blakely, J A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

FEMALE; HEART; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SURVIVAL;

EID: 0034706419     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.19.2897     Document Type: Review

References (13)

1. Hormone therapy to prevent disease and prolong life in postmenopausal women
2. Postmenopausal estrogen and prevention bias
3. Pre-existing risk factor profiles in users and non-users of hormone replacement therapy: Prospective cohort study in Gothenburg, Sweden
4. Hormone replacement therapy and heart disease prevention: Experimentation trumps observation
5. Heart and Estrogen/Progestin Replacement Study (HERS): Design, methods and baseline characteristics
6. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
7. Estrogen replacement therapy: A survey of older women's attitudes
8. The HERS trial results: Paradigms lost?
9. Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials
10. AHA/ ACC Scientific Statement: Consensus Panel Statement: Guide to preventive cardiology for women
11. Prescribing hormone replacement therapy for menopausal symptoms
12. The Canadian Consensus Conference on Menopause and Osteoporosis, I: Consensus statements
13. Effects of an intensive diet and exercise program on lipids in postmenopausal women